Cite
APA Citation
Kato, K., Shah, M. A., Enzinger, P. C., Bennouna, J., Shen, L., Adenis, A., Sun, J., Cho, B. C., Ozguroglu, M., Kojima, T., Kostorov, V., Hierro, C., Zhu, Y., Shah, S., Bhagia, P., & Doi, T. (n.d.). 785TiPPhase III KEYNOTE-590 study of chemotherapy + pembrolizumab versus chemotherapy + placebo as first-line therapy for patients (Pts) with advanced esophageal or esophagogastric junction (E/EGJ) cancer. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095477370.0x000033